Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)

SHE:300841 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	943.13	1,001	1,039	651.46	926.88	1,145
Short-Term Investments	-	-	-	-	-	20
Trading Asset Securities	-	-	-	-	-	180
Cash & Short-Term Investments	943.13	1,001	1,039	651.46	926.88	1,345
Cash Growth	23.71%	-3.66%	59.54%	-29.71%	-31.11%	456.83%
Accounts Receivable	1,316	1,299	1,411	1,287	837.18	352.68
Other Receivables	1.38	0.78	16.38	17.72	2.58	2.61
Receivables	1,317	1,300	1,427	1,305	839.76	355.29
Inventory	147.38	176.88	173.54	153.65	105.49	49.92
Other Current Assets	8.59	10.14	17.09	35.19	70.46	28.81
Total Current Assets	2,416	2,488	2,657	2,145	1,943	1,780
Property, Plant & Equipment	902.49	958.95	961.29	985.45	488.72	202.13
Long-Term Investments	412.51	416.38	477.37	502.47	468.57	108
Other Intangible Assets	15.89	17.51	15.38	17.23	18.77	21.75
Long-Term Deferred Tax Assets	4.15	2.07	-	-	7.04	0.45
Long-Term Deferred Charges	184.7	142.52	94.39	53.76	36.07	25.12
Other Long-Term Assets	1.71	2.15	3.94	7.05	56.29	10.71
Total Assets	3,937	4,028	4,209	3,711	3,018	2,148
Accounts Payable	1.98	5.9	7.13	34.14	6.06	5.86
Accrued Expenses	22.85	256.31	349.01	264.37	211.81	115
Short-Term Debt	149.88	186.89	190.91	109.3	-	-
Current Portion of Long-Term Debt	-	-	-	1	-	-
Current Portion of Leases	-	-	-	0.31	0.59	-
Current Income Taxes Payable	22.68	2.3	27.71	12.58	21.97	14.12
Current Unearned Revenue	0.44	1	0.3	0.23	-	-
Other Current Liabilities	215.05	113.97	106.67	189.78	98.5	35.34
Total Current Liabilities	412.88	566.37	681.72	611.71	338.94	170.33
Long-Term Debt	-	-	-	15.75	-	-
Long-Term Leases	-	-	-	-	0.31	-
Long-Term Unearned Revenue	8.37	6.17	6.2	-	-	-
Long-Term Deferred Tax Liabilities	-	-	2.5	3.96	4.73	-
Other Long-Term Liabilities	9.57	7.54	4.79	3.98	3.77	2.92
Total Liabilities	430.82	580.07	695.22	635.4	347.74	173.24
Common Stock	129.95	132.95	134.65	134.65	90	60
Additional Paid-In Capital	861.15	1,082	1,180	1,184	1,220	1,238
Retained Earnings	2,516	2,456	2,323	1,881	1,416	676.85
Treasury Stock	-	-224.34	-123.1	-123.1	-55.88	-
Shareholders' Equity	3,507	3,448	3,514	3,076	2,670	1,974
Total Liabilities & Equity	3,937	4,028	4,209	3,711	3,018	2,148
Total Debt	149.88	186.89	190.91	126.35	0.9	-
Net Cash (Debt)	793.25	814.44	848.45	525.11	925.98	1,345
Net Cash Growth	45.31%	-4.01%	61.58%	-43.29%	-31.18%	480.87%
Net Cash Per Share	6.10	6.19	6.34	3.92	6.88	11.39
Filing Date Shares Outstanding	129.95	129.95	133.75	133.75	134.46	135
Total Common Shares Outstanding	129.95	129.95	133.75	133.75	134.5	135
Working Capital	2,003	1,922	1,975	1,533	1,604	1,609
Book Value Per Share	26.99	26.53	26.27	23.00	19.85	14.63
Tangible Book Value	3,491	3,430	3,499	3,058	2,652	1,953
Tangible Book Value Per Share	26.86	26.40	26.16	22.87	19.71	14.46
Buildings	-	609.54	450.84	307.46	166.34	58.11
Machinery	-	568.27	548.01	276.66	177.54	100.53
Construction In Progress	-	3.04	112.25	523.35	238.71	127.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.